These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 5772793)

  • 1. The effect of corticotherapy on fibrinolysis in viral hepatitis.
    Nowak A; Woźniak M; Fojt E
    Pol Med J; 1969; 8(2):336-42. PubMed ID: 5772793
    [No Abstract]   [Full Text] [Related]  

  • 2. [Behavior of Owren's Thrombotest in acute viral hepatitis, viral heaptitis of prolonged duration, acute post-hepatitis atrophy of the liver and its relation to various treatments].
    Matano F; Manzillo G; Ferraro T; Di Stasio G
    G Mal Infett Parassit; 1968 Dec; 20(12):963-73. PubMed ID: 5717093
    [No Abstract]   [Full Text] [Related]  

  • 3. [Presence of alpha 1-fetoprotein in adults during viral hepatitis treated by corticotherapy].
    Geffroy Y; Denis P; Colin R; Sauger F; Matray F; Fondimare A
    Presse Med (1893); 1970 May; 78(24):1107-8. PubMed ID: 5422817
    [No Abstract]   [Full Text] [Related]  

  • 4. [Fibrinolytic activity of the blood in viral hepatitis with acute liver necrosis].
    Zhitar' VD
    Ter Arkh; 1975; 47(8):55-61. PubMed ID: 1188651
    [No Abstract]   [Full Text] [Related]  

  • 5. The influence of corticotherapy on the blood proteolytic activity in viral hepatitis.
    Gibiński K; Gonciarz Z; Mandecki T; Fojt E; Maraszek J
    Arch Immunol Ther Exp (Warsz); 1965; 13(6):639-44. PubMed ID: 5865328
    [No Abstract]   [Full Text] [Related]  

  • 6. The present status of corticosteroid therapy in liver diseases.
    Tygstrup N
    Scand J Gastroenterol; 1969; 4(5):393-5. PubMed ID: 4900647
    [No Abstract]   [Full Text] [Related]  

  • 7. [Reflections on prednisone therapy of patients with liver diseases].
    Teichmann W
    Dtsch Z Verdau Stoffwechselkr; 1970; 30(1):25-7. PubMed ID: 5501421
    [No Abstract]   [Full Text] [Related]  

  • 8. [Short-term alternating corticotherapy with single doses at 48 hour intervals in acute viral hepatitis].
    Căruntu F; Angelescu C; Predoviciu F
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1976; 28(3):205-10. PubMed ID: 7827
    [No Abstract]   [Full Text] [Related]  

  • 9. [Coagulation and anticoagulation systems of blood in viral hepatitis during pregnancy].
    Arakelov RA
    Ter Arkh; 1972 Oct; 44(10):65-8. PubMed ID: 4659389
    [No Abstract]   [Full Text] [Related]  

  • 10. Fibrinolytic activity of blood in hepatic disorders.
    Varma SB; Misra NP
    Indian J Med Sci; 1973 May; 27(5):384-7. PubMed ID: 4746239
    [No Abstract]   [Full Text] [Related]  

  • 11. [Leucine aminopeptidase and cystinyl aminopeptidase activity of serum during the course of viral hepatitis, with reference to the effect of cortico therapy].
    Drozdz H
    Folia Med Cracov; 1969; 11(1):103-23. PubMed ID: 5802127
    [No Abstract]   [Full Text] [Related]  

  • 12. [Determination of fibrinolytic and antifibrinolytic activity of blood in epidemic Botkin's disease].
    Arakelov RA; Abagian IA
    Zh Eksp Klin Med; 1969; 9(4):61-3. PubMed ID: 5376572
    [No Abstract]   [Full Text] [Related]  

  • 13. [Determination of some blood clotting and fibrinolytic factors in patients with viral hepatitis].
    Przyjemski J; Chrostowska H; Ellert-Zygadhowska J; Krzysztofowicz J
    Wiad Lek; 1975 Apr; 28(7):533-42. PubMed ID: 1130045
    [No Abstract]   [Full Text] [Related]  

  • 14. Alterations in fibrinolysis and coagulation associated with cardiopulmonary bypass.
    Porter JM; Silver D
    J Thorac Cardiovasc Surg; 1968 Dec; 56(6):869-78. PubMed ID: 5722114
    [No Abstract]   [Full Text] [Related]  

  • 15. [Relations among blood sedimentation rate, alpha-2 and gamma globulins and fibrinogen in acute viral hepatitis, cirrhosis and chronic hepatitis].
    Nuhoglu A; Bolükoglu MA; Aküzümcü O; Goksel V
    Rev Med Moyen Orient; 1967; 24(3):220-5. PubMed ID: 4180032
    [No Abstract]   [Full Text] [Related]  

  • 16. [Study of inhibitors of fibrinolysis in patients with hepatic cirrhosis].
    Teodorescu P; Lilis M; Câmpeanu A; Ionăşescu R; Ionescu-Stoian F
    Med Interna (Bucur); 1967 Nov; 19(11):1283-91. PubMed ID: 5590400
    [No Abstract]   [Full Text] [Related]  

  • 17. Influence of prednisone upon course of epidemical hepatitis.
    Dulicek K
    Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove; 1968; 11(3):371-85. PubMed ID: 5254011
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effect of prednisone treatment in the acute phase of viral hepatitis on the incidence of late post-hepatitic hepatorpathy from 1 to 3 years after the disease. (Statistical evaluation of 187 cases)].
    Da Villa G; Fiorentino F; Piccinino F
    G Mal Infett Parassit; 1966 Dec; 18(12):835-40. PubMed ID: 5998986
    [No Abstract]   [Full Text] [Related]  

  • 19. [The value of studies on the clotting mechanism for the diagnosis of liver diseases. II. Hepatitis and fibrinolysis].
    de Vries SI; Rutgers MA
    Ned Tijdschr Geneeskd; 1965 Oct; 109(41):1911-5. PubMed ID: 5848858
    [No Abstract]   [Full Text] [Related]  

  • 20. [The effect of prednisolone on the blood coagulation system in chronic hepatitis].
    Krutovskaia OV
    Klin Med (Mosk); 1967 Aug; 45(8):70-3. PubMed ID: 5610475
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.